Recent Insider Transactions - Monte Rosa Therapeutics (NASDAQ: GLUE)

Company

Name / Role

Date

Type

Price

# Shares

Value

Balance

NASDAQ GLUE Monte Rosa Therapeutics

Versant Venture Capital VI, L.P. / 10 percent owner

10/28/2024

Sell

$9.66

89,990

$869K

2.01M

NASDAQ GLUE Monte Rosa Therapeutics

Versant Venture Capital VI, L.P. / 10 percent owner

10/29/2024

Sell

$9.08

52,305

$475K

1.59M

NASDAQ GLUE Monte Rosa Therapeutics

Versant Venture Capital VI, L.P. / 10 percent owner

10/29/2024

Sell

$9.41

15,600

$147K

1.57M

NASDAQ GLUE Monte Rosa Therapeutics

Versant Venture Capital VI, L.P. / 10 percent owner

09/20/2024

Sell

$6.53

1.13M

$7.395M

5.10M

NASDAQ GLUE Monte Rosa Therapeutics

Versant Venture Capital VI, L.P. / 10 percent owner

09/11/2024

Sell

$6.00

541,897

$3.251M

6.26M

NASDAQ GLUE Monte Rosa Therapeutics

Versant Venture Capital VI, L.P. / 10 percent owner

09/12/2024

Sell

$6.00

16,047

$96K

6.24M

NASDAQ GLUE Monte Rosa Therapeutics

Versant Venture Capital VI, L.P. / 10 percent owner

09/13/2024

Sell

$6.16

9,269

$57K

6.23M

NASDAQ GLUE Monte Rosa Therapeutics

Janku Filip / officer: Chief Medical Officer

09/13/2024

Buy

$7.56

30,000

$227K

30,000